Browsing: Therapeutics

This article was written byFollowI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a…

This article was written byFollowI am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide…

Major U.S. stock indices closed higher Tuesday, with the Dow Jones Industrial Average up 0.16% at 48,442.41, the S&P 500 advancing 0.46% to 6,909.79, and the…

Nektar Therapeutics (NASDAQ:NKTR) stock is trading lower Monday afternoon as the market continues to assess mixed topline results from the Phase 2b REZOLVE-AA trial of rezpegaldesleukin.…

This article was written byFollowWith a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines, and market dynamics. After completing my…

FollowPlay Earnings CallPlay Earnings Call 4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential December 17,…

Michelle CorralVice President of Investor Relationship & Corporate Communications Hi, everyone, and thank you for joining us today. I’m Michelle Corral, Vice President of Corporate Communications…

Conference Call Participants Evan Seigerman – BMO Capital Markets Equity ResearchSeamus Fernandez – Guggenheim Securities, LLC, Research DivisionTerence Flynn – Morgan Stanley, Research DivisionYasmeen Rahimi -…

FollowPlay Earnings CallPlay Earnings Call Catalyst Pharmaceuticals, Inc. (CPRX) BofA Securities CNS Therapeutics Virtual Conference 2025 December 8, 2025 12:35 PM EST Company Participants Richard John…

FollowPlay Earnings CallPlay Earnings Call Supernus Pharmaceuticals, Inc. (SUPN) BofA Securities CNS Therapeutics Virtual Conference 2025 December 8, 2025 10:45 AM EST Company Participants Jack Khattar…